A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for Eureka Therapeutics, Inc..

Industry: Biological Products, (No Disgnostic Substances) (Office Of Life Sciences)
Business address: 5858 Horton St Ste 170, Emeryville, CA, 94608
State of incorporation: DE
Fiscal year end: 31 December

Get insider transactions for this reporting owner

Eureka Therapeutics, Inc. has filed 11 SEC EDGAR filings since 08 Jan 2007

Recent SEC filings for Eureka Therapeutics, Inc. including SC 13D, 3, D and more.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
SC 13D	Open SC 13D document	View SEC filing for SC 13D	SCHEDULE 13D	30 Oct 2023
3	Open 3 document	View SEC filing for 3		10 Oct 2023	29 Sep 2023	001-40608
D	Open D document	View SEC filing for D		17 May 2023		021-481903
D	Open D document	View SEC filing for D		24 Jan 2020		021-358835
D	Open D document	View SEC filing for D		18 Jun 2018		021-314816
D/A	Open D/A document	View SEC filing for D/A		30 May 2017		021-276040
D	Open D document	View SEC filing for D		12 Dec 2016		021-276040
D	Open D document	View SEC filing for D		22 Sep 2014		021-225088

Eureka Therapeutics, Inc. files with the SEC under CIK 0001386560. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.